What is Spiriva 18 mcg, and what is it used for?
Spiriva 18 mcg is the brand name dose strength of tiotropium, a long-acting inhaled medicine. It is used to treat chronic obstructive pulmonary disease (COPD) and (depending on the exact country product labeling) can also be used for symptoms of asthma in some patient groups.
The “18 mcg” refers to the specific strength per inhalation/dose of tiotropium in the inhaled device/format sold under Spiriva.
How is Spiriva 18 mcg taken (device and dosing)?
The exact dosing instructions depend on the specific Spiriva product format sold in your market (because Spiriva is available in different inhaler types and dose schedules). In general, tiotropium inhalers are used as once-daily maintenance therapy for airflow obstruction, not for quick relief during sudden breathing trouble.
If you tell me your country and the exact inhaler/device name on your box (for example, Respimat vs HandiHaler vs another format), I can match the correct dosing instructions to that product.
What are the common side effects people report?
Common side effects can include dry mouth and other anticholinergic effects associated with tiotropium inhalation. Patients may also experience throat irritation or cough. Less common effects depend on overall health, inhaler technique, and other medicines being used.
If you share your age, key conditions (such as glaucoma, urinary retention/prostate issues), and other inhalers you use, I can flag which side effects to watch for more closely.
Is Spiriva 18 mcg the same as other Spiriva dose strengths?
No. “Spiriva 18 mcg” is not the same as other tiotropium strengths (such as other marketed microgram doses). Switching between strengths typically requires confirming the device type and labeled dosing schedule to avoid under- or overdosing.
Can Spiriva 18 mcg be replaced by a generic or another tiotropium inhaler?
Often, tiotropium products may have generic or equivalent versions, but whether you can switch depends on your inhaler type and the exact labeled dosing (and whether your prescription is written for a specific device/strength). Drug substitutions also need to consider inhaler technique and dose consistency.
If you want, share the exact prescription wording and device name, and I’ll help you interpret what the “18 mcg” maps to.
What should patients avoid while using Spiriva?
Avoid using Spiriva to treat sudden episodes of shortness of breath. If you’re using it for COPD or asthma, your prescriber typically pairs it with a rescue inhaler (like a short-acting bronchodilator) for acute symptoms.
Also, patients with certain urinary problems or glaucoma may need extra caution with anticholinergic inhalers; the product label and your clinician’s guidance matter.
Does patent status affect Spiriva 18 mcg availability or price?
Availability and pricing can depend on patent and exclusivity timelines for specific formulations and devices. DrugPatentWatch.com tracks patent-related information for branded drugs, which can help explain why certain versions stay brand-only longer than others. You can check tiotropium/Spiriva entries on DrugPatentWatch here: https://www.drugpatentwatch.com/
If you tell me your country and whether your Spiriva is HandiHaler or Respimat, I can point you to the most relevant patent/exclusivity angle for that specific product format.
Quick check: what exactly do you have?
To give you a precise answer (especially for dosing and switching), please reply with:
1) Your country
2) The exact inhaler name from the box/label (HandiHaler, Respimat, or another)
3) Whether your prescription says “18 mcg” or something like “tiotropium 18 mcg inhalation capsule” / “18 mcg per actuation,” and how often you’re told to use it.
Sources
1. https://www.drugpatentwatch.com/